Artikel
Lizenziert
Nicht lizenziert
Erfordert eine Authentifizierung
Non-invasive assessment of liver fibrosis: it is time for laboratory medicine
-
Giada Sebastiani
Veröffentlicht/Copyright:
20. Oktober 2010
Abstract
Chronic liver diseases (CLDs) represent a major cause of morbidity and mortality worldwide. In all etiologies of CLDs, staging of liver fibrosis is essential for both prognosis and management. Until a few years ago, liver biopsy was the only tool for the diagnosis of liver fibrosis in patients with CLDs. However, liver biopsy is an invasive and costly procedure. More recently, various serum biomarkers and laboratory tests have been proposed as surrogates of liver histology. Due to inadequate diagnostic accuracy or to lack of sufficient validation, guidelines still do not recommend them as a substitute for liver biopsy that is still considered the gold standard for the diagnosis of liver fibrosis. Notably, non-invasive serum biomarkers, when combined, may reduce by 50%–80% the number of liver biopsies needed for correctly classifying hepatic fibrosis. However, liver biopsy cannot be avoided completely, but should be used in those cases in which non-invasive methods show poor accuracy. In this view, serum biomarkers and liver biopsy represent a union between laboratory medicine and hepatology.
Keywords: combination algorithms; diagnostic performance; liver biopsy; liver fibrosis; non-invasive biomarkers; staging
Received: 2010-3-10
Accepted: 2010-5-25
Published Online: 2010-10-20
Published in Print: 2011-01-01
©2011 by Walter de Gruyter Berlin New York
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Artikel in diesem Heft
- Publisher's Note
- Publisher's Note
- Editorials
- Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors
- Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?
- Pharmacogenomics of alcohol metabolism: implications for legal testing
- Reviews
- Non-invasive assessment of liver fibrosis: it is time for laboratory medicine
- Application of proteomics to prenatal screening and diagnosis for aneuploidies
- Opinion Paper
- Harmonization of free thyroid hormone tests: a mission impossible?
- Genetics and Molecular Diagnostics
- A polymorphism in the 5’ UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients
- Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population
- General Clinical Chemistry and Laboratory Medicine
- Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis
- Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application
- A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease
- Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies
- Interlaboratory study of free monoclonal immunoglobulin light chain quantification
- Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease
- Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus
- Introduction of a new cobalamin (vitamin B12) assay: lessons from a flawed validation study
- Prevalence and course of pseudothrombocytopenia in outpatients
- Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis
- Validation and Outcome Studies Reference Values and Biological Variations
- Age- and gender-dependent changes in circulating concentrations of tumor necrosis factor-α, soluble tumor necrosis factor receptor-1 and sulfated glycosaminoglycan in healthy people
- Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity
- Cross-sectional study of biomarkers of exposure and biological effect on monozygotic twins discordant for smoking
- Cancer Diagnostics
- Evaluation of ovarian cancer biomarkers in subjects with benign asbestos-related pleural diseases
- Development of a fluorescent microsphere immunoassay for cystatin B (CSTB) in serum of patients with hepatocellular carcinoma
- Letters to the Editor
- Factors reducing hemolysis rates in blood samples from the emergency department
- Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
- Crystal-associated pseudoeosinophilia of synovial fluid
Schlagwörter für diesen Artikel
combination algorithms;
diagnostic performance;
liver biopsy;
liver fibrosis;
non-invasive biomarkers;
staging
Artikel in diesem Heft
- Publisher's Note
- Publisher's Note
- Editorials
- Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors
- Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?
- Pharmacogenomics of alcohol metabolism: implications for legal testing
- Reviews
- Non-invasive assessment of liver fibrosis: it is time for laboratory medicine
- Application of proteomics to prenatal screening and diagnosis for aneuploidies
- Opinion Paper
- Harmonization of free thyroid hormone tests: a mission impossible?
- Genetics and Molecular Diagnostics
- A polymorphism in the 5’ UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients
- Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population
- General Clinical Chemistry and Laboratory Medicine
- Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis
- Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application
- A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease
- Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies
- Interlaboratory study of free monoclonal immunoglobulin light chain quantification
- Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease
- Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus
- Introduction of a new cobalamin (vitamin B12) assay: lessons from a flawed validation study
- Prevalence and course of pseudothrombocytopenia in outpatients
- Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis
- Validation and Outcome Studies Reference Values and Biological Variations
- Age- and gender-dependent changes in circulating concentrations of tumor necrosis factor-α, soluble tumor necrosis factor receptor-1 and sulfated glycosaminoglycan in healthy people
- Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity
- Cross-sectional study of biomarkers of exposure and biological effect on monozygotic twins discordant for smoking
- Cancer Diagnostics
- Evaluation of ovarian cancer biomarkers in subjects with benign asbestos-related pleural diseases
- Development of a fluorescent microsphere immunoassay for cystatin B (CSTB) in serum of patients with hepatocellular carcinoma
- Letters to the Editor
- Factors reducing hemolysis rates in blood samples from the emergency department
- Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
- Crystal-associated pseudoeosinophilia of synovial fluid
